Phaos Technology Holdings (Cayman) (POAS) Common Equity (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Common Equity came in at -$2.7 million in Q4 2025, down 83.51% on a QoQ basis from -$1.5 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Common Equity (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Common Equity data on file, last reported at -$2.7 million in Q4 2025.
- Quarterly Common Equity changed N/A year-over-year to -$2.7 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was -$2.7 million (changed N/A YoY) and the FY2025 annual result came in at -$1.5 million, down 167.79% from the prior year.
- Common Equity declined to -$2.7 million in Q4 2025, from -$1.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $2.2 million in Q2 2024 to a low of -$2.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.24 Mn | 4.20 Mn | - | -2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -2.69 Mn |
| Apr 30, 2025 | -1.47 Mn |
| Apr 30, 2024 | 2.17 Mn |